Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice
Open Access
- 1 September 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 175 (5) , 3053-3059
- https://doi.org/10.4049/jimmunol.175.5.3053
Abstract
CD4+CD25+Foxp3+ regulatory T cells (Treg) are critical for controlling autoimmunity. Evidence suggests that Treg development, peripheral maintenance, and suppressive function are dependent on Ag specificity. However, there is little direct evidence that the Treg responsible for controlling autoimmunity in NOD mice or other natural settings are Ag specific. In fact, some investigators have argued that polyclonal Ag-nonspecific Treg are efficient regulators of immunity. Thus, the goal of this study was to identify, expand, and characterize islet Ag-specific Treg in NOD mice. Ag-specific Treg from NOD mice were efficiently expanded in vitro using IL-2 and beads coated with recombinant islet peptide mimic-MHC class II and anti-CD28 mAb. The expanded Ag-specific Treg expressed prototypic surface markers and cytokines. Although activated in an Ag-specific fashion, the expanded Treg were capable of bystander suppression both in vitro and in vivo. Importantly, the islet peptide mimic-specific Treg were more efficient than polyclonal Treg in suppressing autoimmune diabetes. These results provide a direct demonstration of the presence of autoantigen-specific Treg in the natural setting that can be applied as therapeutics for organ-specific autoimmunity.Keywords
This publication has 17 references indexed in Scilit:
- Therapeutic vaccination using CD4+CD25+antigen-specific regulatory T cellsProceedings of the National Academy of Sciences, 2004
- Recognition of the Peripheral Self by Naturally Arising CD25+ CD4+ T Cell ReceptorsImmunity, 2004
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponsesAnnual Review of Immunology, 2004
- Peptide-MHC Class II Dimers as Therapeutics to Modulate Antigen-Specific T Cell Responses in Autoimmune DiabetesThe Journal of Immunology, 2003
- Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes DevelopmentThe Journal of Immunology, 2003
- Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic MiceThe Journal of Immunology, 2001
- B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune DiabetesPublished by Elsevier ,2000
- Peripheral Autoantigen Induces Regulatory T Cells that Prevent AutoimmunityThe Journal of Experimental Medicine, 1999